Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1575-1582

  Robciuc, Marius R ^a   Naukkarinen, Jussi ^a,b,c   Ortega Alonso, Alfredo ^b   Tyynismaa, Henna ^b   Raivio, Taneli ^b,d   Rissanen, Aila ^c   Kaprio, Jaakko ^a,b   Ehnholm, Christian ^a   Jauhiainen, Matti ^a,b   Pietiläinen, Kirsi H ^b,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Angptl4; Heritability; Obesity discordant monozygotic twins; Twin pairs

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; ANGPTL4 GENE; ARTICLE; BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIZYGOTIC TWINS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE LOCATION; GENETIC CORRELATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; MONOZYGOTIC TWINS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TISSUE DISTRIBUTION; TWIN DISCORDANCE;

ADIPOSE TISSUE; ANGIOPOIETINS; BIOPSY; BLOOD GLUCOSE; BLOOD PROTEINS; BODY COMPOSITION; BODY MASS INDEX; FEMALE; FINLAND; GENE EXPRESSION; HUMANS; LONGITUDINAL STUDIES; MALE; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 79960689146     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P015867     Document Type: Article

References (37)

1. Yoshida, K., T. Shimizugawa, M. Ono, and H. Furukawa. 2002. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43: 1770-1772. (Pubitemid 35315796)
2. Sanderson, L. M., T. Degenhardt, A. Koppen, E. Kalkhoven, B. Desvergne, M. Muller, and S. Kersten. 2009. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol. Cell. Biol. 29: 6257-6267.
3. Kim, H. K., B. S. Youn, M. S. Shin, C. Namkoong, K. H. Park, J. H. Baik, J. B. Kim, J. Y. Park, K. U. Lee, Y. B. Kim, et al. 2010. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes. 59: 2772-2780.
4. Zhu, P., M. J. Tan, R. L. Huang, C. K. Tan, H. C. Chong, M. Pal, C. R. Lam, P. Boukamp, J. Y. Pan, S. H. Tan, et al. 2011. Angiopoietin-like 4 protein elevates the prosurvival intracellular O(2)(-):H(2) O(2) ratio and confers anoikis resistance to tumors. Cancer Cell. 19: 401-415.
5. Galaup, A., A. Cazes, S. Le Jan, J. Philippe, E. Connault, E. Le Coz, H. Mekid, L. M. Mir, P. Opolon, P. Corvol, et al. 2006. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc. Natl. Acad. Sci. USA. 103: 18721-18726.
6. Padua, D., X. H. Zhang, Q. Wang, C. Nadal, W. L. Gerald, R. R. Gomis, and J. Massague. 2008. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 133: 66-77. (Pubitemid 351442989)
7. Ito, Y., Y. Oike, K. Yasunaga, K. Hamada, K. Miyata, S. Matsumoto, S. Sugano, H. Tanihara, Y. Masuho, and T. Suda. 2003. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res. 63: 6651-6657. (Pubitemid 37322943)
8. Le Jan, S., C. Amy, A. Cazes, C. Monnot, N. Lamande, J. Favier, J. Philippe, M. Sibony, J. M. Gasc, P. Corvol, et al. 2003. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162: 1521-1528.
9. Goh, Y. Y., M. Pal, H. C. Chong, P. Zhu, M. J. Tan, L. Punugu, C. K. Tan, R. L. Huang, S. K. Sze, M. B. Tang, et al. 2010. Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J. Biol. Chem. 285: 32999-3009.
10. Lichtenstein, L., F. Mattijssen, N. J. de Wit, A. Georgiadi, G. J. Hooiveld, R. van der Meer, Y. He, L. Qi, A. Koster, J. T. Tamsma, et al. 2010. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 12: 580-592.
11. Clement, L. C., C. Avila-Casado, C. Mace, E. Soria, W. W. Bakker, S. Kersten, and S. S. Chugh. 2011. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat. Med. 17: 117-122.
12. Cazes, A., A. Galaup, C. Chomel, M. Bignon, N. Brechot, S. Le Jan, H. Weber, P. Corvol, L. Muller, S. Germain, et al. 2006. Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ. Res. 99: 1207-1215.
13. Robciuc, M. R., E. Tahvanainen, M. Jauhiainen, and C. Ehnholm. 2010. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J. Lipid Res. 51: 824-831.
14. Chomel, C., A. Cazes, C. Faye, M. Bignon, E. Gomez, C. Ardidie-Robouant, A. Barret, S. Ricard-Blum, L. Muller, S. Germain, et al. 2009. Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. FASEB J. 23: 940-949.
15. Mandard, S., F. Zandbergen, E. van Straten, W. Wahli, F. Kuipers, M. Muller, and S. Kersten. 2006. The fasting-induced adipose factor/angiopoietin- like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281: 934-944.
16. Kersten, S. 2009. Angiopoietin-like proteins and lipid metabolism. In Cellular Lipid Metabolism. C. Ehnholm, editor. Springer, Heidelberg, Germany. 237-250.
17. Lichtenstein, L., and S. Kersten. 2010. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta. 1801: 415-420.
18. Romeo, S., L. A. Pennacchio, Y. Fu, E. Boerwinkle, A. Tybjaerg-Hansen, H. H. Hobbs, and J. C. Cohen. 2007. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39: 513-516.
19. Romeo, S., W. Yin, J. Kozlitina, L. A. Pennacchio, E. Boerwinkle, H. H. Hobbs, and J. C. Cohen. 2009. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 119: 70-79.
20. Backhed, F., J. K. Manchester, C. F. Semenkovich, and J. I. Gordon. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA. 104: 979-984.
21. Kersten, S., S. Mandard, N. S. Tan, P. Escher, D. Metzger, P. Chambon, F. J. Gonzalez, B. Desvergne, and W. Wahli. 2000. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275: 28488-28493.
22. Yoon, J. C., T. W. Chickering, E. D. Rosen, B. Dussault, Y. Qin, A. Soukas, J. M. Friedman, W. E. Holmes, and B. M. Spiegelman. 2000. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20: 5343-5349.
23. Badman, M. K., P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier. 2007. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5: 426-437. (Pubitemid 46825495)
24. Stejskal, D., M. Karpisek, H. Reutova, V. Humenanska, M. Petzel, P. Kusnierova, I. Vareka, R. Varekova, and P. Stejskal. 2008. Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA. Gen. Physiol. Biophys. 27: 59-63.
25. Tyynismaa, H., T. Raivio, A. Hakkarainen, A. Ortega-Alonso, N. Lundbom, J. Kaprio, A. Rissanen, A. Suomalainen, and K. H. Pietilainen. 2010. Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins. J. Clin. Endocrinol. Metab. 96: E351-E355.
26. Kaprio, J. 2006. Twin studies in Finland 2006. Twin Res. Hum. Genet. 9: 772-777.
27. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
28. Kersten, S., L. Lichtenstein, E. Steenbergen, K. Mudde, H. F. Hendriks, M. K. Hesselink, P. Schrauwen, and M. Muller. 2009. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 29: 969-974
29. Kolditz, C. I., and D. Langin. 2010. Adipose tissue lipolysis. Curr. Opin. Clin. Nutr. Metab. Care. 13: 377-381.
30. Talmud, P. J., M. Smart, E. Presswood, J. A. Cooper, V. Nicaud, F. Drenos, J. Palmen, M. G. Marmot, S. M. Boekholdt, N. J. Wareham, et al. 2008. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk. Arterioscler. Thromb. Vasc. Biol. 28: 2319-2325.
31. Legry, V., S. Bokor, D. Cottel, L. Beghin, G. Catasta, E. Nagy, M. Gonzalez-Gross, A. Spinneker, P. Stehle, D. Molnar, et al. 2009. Associations between common genetic polymorphisms in angiopoietin-like proteins 3 and 4 and lipid metabolism and adiposity in European adolescents and adults. J. Clin. Endocrinol. Metab. 94: 5070-5077.
32. Koliwad, S. K., T. Kuo, L. E. Shipp, N. E. Gray, F. Backhed, A. Y. So, R. V. Farese, Jr., and J. C. Wang. 2009. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J. Biol. Chem. 284: 25593-25601.
33. Smart-Halajko, M. C., M. R. Robciuc, J. A. Cooper, M. Jauhiainen, M. Kumari, M. Kivimaki, K. T. Khaw, S. M. Boekholdt, N. J. Wareham, T. R. Gaunt, et al. 2010. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler. Thromb. Vasc. Biol. 30: 2277-2282.
34. Gealekman, O., A. Burkart, M. Chouinard, S. M. Nicoloro, J. Straubhaar, and S. Corvera. 2008. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am. J. Physiol. Endocrinol. Metab. 295: E1056-E1064.
35. Teslovich, T. M., K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou, M. Koseki, J. P. Pirruccello, S. Ripatti, D. I. Chasman, C. J. Willer, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466: 707-713.
36. Mai, K., J. Andres, K. Biedasek, J. Weicht, T. Bobbert, M. Sabath, S. Meinus, F. Reinecke, M. Mohlig, M. O. Weickert, et al. 2009. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes. 58: 1532-1538.
37. Kharitonenkov, A., and A. B. Shanafelt. 2009. FGF21: a novel prospect for the treatment of metabolic diseases. Curr. Opin. Investig. Drugs. 10: 359-364.